Statistics for Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2
Total visits
| views | |
|---|---|
| Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2 | 2 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
File Visits
| views | |
|---|---|
| Clark2021LongTerm-CCBYNC.pdf | 4 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Franklin | 2 |